Mike Hennessy Jr, Chairman and CEO

The June issue of Dermatology Times highlights the latest advances in skin cancer, psoriasis, atopic dermatitis, hidradenitis suppurativa, and emerging dermatology technologies.

New data unveiled at AAD 2026 emphasized the growing role of targeted immune modulation and systemic therapies in dermatologic care.

A cover feature by Nicole A. Negbenebor, MD, FAAD, examines the growing leadership role of women in Mohs micrographic surgery for nonmelanoma skin cancer.

Dermatology Times recently concluded its second annual Horizons in Advanced Practice meeting in Tampa, Florida, featuring nurse practitioners and physician assistants from across the country.

This issue highlights clinical insights relevant to inflammatory conditions in diverse populations, emphasizing practical strategies for everyday practice.

Explore the latest advancements in dermatology for 2026, focusing on clinical innovation, emerging research, and practical insights for improved patient care.

Dermatology Times highlights 2025's innovations in dermatology, featuring new therapies, expert insights, and a look ahead to 2026 advancements.

Explore the latest FDA approvals in dermatology, including treatments for eczema and psoriasis, and gain insights on chronic spontaneous urticaria.

Explore the vital role of dermatology in breast cancer care, from early detection to managing skin issues related to treatment and radiation.

Explore the latest advancements in psoriasis treatment, including pediatric care and innovative therapies, during Psoriasis Action Month. Stay informed!

Explore the latest advancements in dermatology in our July issue, from innovative treatments to AI in skin care, shaping the future of skin health and research.

Discover the latest advancements in dermatology in our June issue, including FDA approvals, innovative treatments, and expert insights shaping patient care today.

Explore vital insights on melanoma awareness, skin cancer disparities, and atopic dermatitis management in the latest issue of Dermatology Times.

Explore key takeaways from AAD 2025, rosacea insights, psoriasis updates, and expert interviews in the latest issue of Dermatology Times.

Celebrate Women’s History Month 2025 with insights from leading female dermatologists and expert coverage from the AAD Annual Meeting in Orlando.

Start the new year with a look at top dermatology conferences, expert insights, and the latest research on pigmentary disorders, psoriasis, and antiaging treatments.

We're welcoming 2025 with dermatology innovations, expert insights on chronic hand eczema, and new leadership at Dermatology Times.

A reflection on 2024's dermatology advancements, from FDA approvals to expert insights, setting the stage for another transformative year in 2025.

Join Dermatology Times in celebrating National Healthy Skin Month.

Join Dermatology Times in honoring World Mental Health Day on Oct 10, 2024.

Our August issue covers common back-to-school skin conditions, psoriasis research, OX40 inhibition for atopic dermatitis, and pediatric dermatology meeting highlights.

The first issue of Dermatology Times was published in 1979 to offer clinical insights into a growing health care specialty.

The June issue of Dermatology Times features a collection of articles related to e-cigarette use and skin, Acne Awareness Month, and more.

Our May issue of Dermatology Times spotlights melanoma/skin cancer awareness and more.

In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.

Our March 2024 publication features stories that reflect the sense of growth and newness in the specialty.

This year is already off to a busy start, and Dermatology Times is prepared to provide our readers with the most up-to-date clinical content from innovative studies and FDA approvals to exclusive interviews and expert insights.

Dermatology Times is excited to ring in 2024 with a fresh perspective to amplify our impact, foster creativity, and deliver even more exceptional, compelling content to you—our cherished audience.